BioCryst Pharma (BCRX) Posts Narrower than Expected Q4 Loss
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) reported Q4 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
